New Biologics projects

Cyclic peptides lead to New Biologics, such as highly multi-specific IgG or “Small but multi specific dAb”.

No. Construct Stage
No.1 anti-CTLA-4 pep/anti-PD-1 dAb Lead optimization
No.2 anti-Her2 pep/anti-Her2 dAb Under construction
No.3 anti-IL-6 pep/anti-TNF-α dAb Under construction
No.4 anti-Erk2 pep/GFP Available for R&D (Imaging tool)

(dAb: domain antibody)




Related Products and Services

PUREfrex® RD
Drug Discovery
Drug Discovery